Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26423439 | 0.93 | EGFR (0.39) | EGFRPIK3CDPIK3CAIMPDH2FGFR4 | |
| SCHEMBL26423348 | 0.83 | ALDH1A1 (0.41) | EGFRPIK3CDPIK3CA | |
| SCHEMBL26423404 | 0.83 | ALDH1A1 (0.41) | EGFRPIK3CDPIK3CAIMPDH2FGFR4 | |
| SCHEMBL26423444 | 0.81 | — | — | |
| SCHEMBL26423347 | 0.81 | HASPIN (0.41) | — | |
| SCHEMBL26423346 | 0.81 | HASPIN (0.41) | — | |
| SCHEMBL26423219 | 0.80 | EGFR (0.39) | EGFRPIK3CDPIK3CA | |
| SCHEMBL26423402 | 0.80 | EGFR (0.39) | EGFRPIK3CDPIK3CAIMPDH2FGFR4 | |
| SCHEMBL26423400 | 0.80 | EGFR (0.36) | EGFRPIK3CDPIK3CAIMPDH2FGFR4 | |
| SCHEMBL19758249 | 0.78 | AHR (0.45) | EGFRPIK3CDPIK3CAIMPDH2TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | OCIAD2, OCIAD1, AZI2 | EGFR 1270/4885PIK3CD 2623/4885PIK3CA 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.